Andrea Angius
Senior researcher
Area of interest:
Professional Profile
Andrea Angius is a Researcher Director at the Institute of Genetic and Biomedical Research (IRGB) in Monserrato (Cagliari), Italy. He obtained his degree in Biological Sciences from the University of Cagliari (1992) and a PhD in Biochemistry from the University of Sassari (1999). He has been working at CNR since 1995, became a permanent Researcher in 2000 at the Institute of Molecular Genetics (IGM), and moved to IRGB in 2011.
Since the early stages of his career, Dr. Angius has developed strong expertise in human genetics, large-scale genotyping and next-generation sequencing technologies, strengthened through international research experiences as a visiting scientist at the Marshfield Clinic Mammalian Genotyping Service (USA), the Medical Genetics Unit of IRCCS–CSS Hospital (Italy), and the Medical Research Council Human Genetics Unit (MRC HGU), Edinburgh (UK).
Scientific Leadership and Infrastructure Management
From 1997 onwards, Dr. Angius has played a leading role in the coordination of large-scale genotyping and sequencing projects, with a specific focus on the Sardinian population, collaborating with major international reference laboratories.
He has held key managerial positions in advanced research infrastructures, including Scientific Manager of the CRS4 Next Generation Sequencing (NGS) Core Facility (2010–2014); Laboratory Manager of the Genotyping Laboratory of Sardegna Ricerche (2006–2010). In these roles, he was responsible for strategic planning, technological implementation, project prioritization, and support of national and international research consortia.
Research Projects and Funding
Dr. Angius has been actively involved, both as Principal Investigator and collaborator, in the design, coordination, and management of numerous regional, national, and international funded research projects since 2000. He has secured competitive funding from MIUR, Regional Government of Sardinia, and private Foundations, contributing significantly to the development of genomic research infrastructures and large population-based studies.
Academic and Teaching Activities
Dr. Angius has a long-standing commitment to academic teaching and mentoring. He has served as Associate Professor at the University of Sassari since 2003, delivering approximately 25 academic courses, and has contributed to International Master programs and advanced specialized courses. He has supervised and mentored PhD, Master’s, and undergraduate students at the Universities of Cagliari, Sassari, and Turin. He is currently a member of the Board of Teachers of the PhD School in Biomedical Sciences (Medical Genetics, Metabolic Diseases and Nutrigenomics) and previously served on the Board of the PhD School in Biomolecular and Biotechnological Sciences.
Editorial and Scientific Impact
Dr. Angius serves as Editorial Board Member of international journals and acts as reviewer for numerous high-impact scientific journals. He has authored or co-authored over 1,000 peer-reviewed publications, with an h-index of 40 (Scopus), reflecting a sustained and impactful contribution to the field of human and population genetics.
Main Research Areas and Contributions
Dr. Angius’ research focuses on: Cancer genetics; Rare Mendelian disorder; Complex diseases; Population and evolutionary genetics; Large-scale sequencing and multi-omics approaches.
His work has led to several landmark achievements, including:
- The creation of the Sardinian genome reference panel, enabling high-resolution GWAS studies of complex diseases such as diabetes and multiple sclerosis (Nature Genetics, 2015).
- Large-scale whole-exome sequencing studies in patients affected by intellectual disability and rare genetic syndromes (e.g. Crisponi, Rubinstein–Taybi, IHPRF1).
- Transcriptomic and eQTL analyses in thousands of individuals to investigate gene expression regulation in complex diseases (Nature Genetics, 2017).
- Population genetics and phylogenetic studies on mitochondrial DNA and Y chromosome, providing insights into the origin and settlement of the Sardinian population and the Mediterranean area (Science, Nature Genetics).
- Transcriptome and miRNA profiling in breast and colorectal cancer using innovative NGS-based approaches.
Most significant publications:
2024
A novel affordable and reliable framework for accurate detection and comprehensive analysis of somatic mutations in cancer Journal Article
In: Int. J. Mol. Sci., 25 (15), pp. 8044, 2024.
2017
Population- and individual-specific regulatory variation in Sardinia Journal Article
In: Nature Genetics, 49 (5), pp. 700–707, 2017, ISSN: 1546-1718.
2016
Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa Journal Article
In: American Journal of Human Genetics, 99 (1), pp. 236–245, 2016, ISSN: 1537-6605.
2015
Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers Journal Article
In: Nature Genetics, 47 (11), pp. 1272–1281, 2015, ISSN: 1546-1718.
2013
Low-pass DNA sequencing of 1200 Sardinians reconstructs European Y-chromosome phylogeny Journal Article
In: Science (New York, N.Y.), 341 (6145), pp. 565–569, 2013, ISSN: 1095-9203.

- Monserrato
070 6754591
ORCID profile: orcid.org/0000-0003-2596-6461